Amneal Pharmaceuticals, Inc.
(NYSE : AMRX)

( )
AMRX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.40%160.110.7%$1208.66m
PFEPfizer Inc. 0.08%37.190.9%$1005.03m
MRKMerck & Co., Inc. 0.00%76.430.7%$966.72m
ABBVAbbVie, Inc. -0.86%106.001.9%$820.34m
BMYBristol-Myers Squibb Co. 0.41%63.841.0%$725.84m
LLYEli Lilly & Co. 0.33%183.131.1%$599.57m
AZNAstraZeneca Plc 1.32%49.841.2%$440.69m
GSKGlaxoSmithKline Plc 0.24%36.130.2%$179.07m
RPRXRoyalty Pharma Plc 1.67%42.120.2%$163.20m
NVSNovartis AG 0.16%86.750.2%$149.07m
VTRSViatris, Inc. 1.85%13.210.0%$129.35m
RGENRepligen Corp. -3.56%205.296.8%$87.69m
CVACCureVac NV 7.28%102.610.0%$83.02m
ATNF180 Life Sciences Corp. -3.06%10.460.0%$62.67m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 2.94%74.920.0%$61.28m

Company Profile

Amneal Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generics and Specialty segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ.